366 related articles for article (PubMed ID: 21762686)
1. Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem.
Vinkers CH; Olivier B; Hanania T; Min W; Schreiber R; Hopkins SC; Campbell U; Paterson N
Eur J Pharmacol; 2011 Oct; 668(1-2):190-3. PubMed ID: 21762686
[TBL] [Abstract][Full Text] [Related]
2. Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination.
Mirza NR; Rodgers RJ; Mathiasen LS
J Pharmacol Exp Ther; 2006 Mar; 316(3):1291-9. PubMed ID: 16339395
[TBL] [Abstract][Full Text] [Related]
3. Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023.
Kohut SJ; Ator NA
Pharmacol Biochem Behav; 2008 Jul; 90(1):65-73. PubMed ID: 18395780
[TBL] [Abstract][Full Text] [Related]
4. Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice.
Mathiasen LS; Mirza NR; Rodgers RJ
Pharmacol Biochem Behav; 2008 Jul; 90(1):19-36. PubMed ID: 18321566
[TBL] [Abstract][Full Text] [Related]
5. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
[TBL] [Abstract][Full Text] [Related]
6. GABA(A) receptor α subunits differentially contribute to diazepam tolerance after chronic treatment.
Vinkers CH; van Oorschot R; Nielsen EØ; Cook JM; Hansen HH; Groenink L; Olivier B; Mirza NR
PLoS One; 2012; 7(8):e43054. PubMed ID: 22912786
[TBL] [Abstract][Full Text] [Related]
7. Drug discrimination analysis of midazolam under a three-lever procedure. II: Differential effects of benzodiazepine receptor agonists.
Sannerud CA; Ator NA
J Pharmacol Exp Ther; 1995 Oct; 275(1):183-93. PubMed ID: 7562548
[TBL] [Abstract][Full Text] [Related]
8. Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors.
Rowlett JK; Spealman RD; Lelas S; Cook JM; Yin W
Psychopharmacology (Berl); 2003 Jan; 165(3):209-15. PubMed ID: 12420154
[TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics.
Rowlett JK; Spealman RD; Lelas S
J Pharmacol Exp Ther; 1999 Dec; 291(3):1233-41. PubMed ID: 10565847
[TBL] [Abstract][Full Text] [Related]
10. Effects of intraseptal zolpidem and chlordiazepoxide on spatial working memory and high-affinity choline uptake in the hippocampus.
Herzog CD; Gandhi C; Bhattacharya P; Walsh TJ
Neurobiol Learn Mem; 2000 Mar; 73(2):168-79. PubMed ID: 10704326
[TBL] [Abstract][Full Text] [Related]
11. A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test.
Mathiasen L; Mirza NR
Psychopharmacology (Berl); 2005 Nov; 182(4):475-84. PubMed ID: 16133136
[TBL] [Abstract][Full Text] [Related]
12. Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties.
Araujo F; Ruano D; Vitorica J
J Pharmacol Exp Ther; 1999 Sep; 290(3):989-97. PubMed ID: 10454469
[TBL] [Abstract][Full Text] [Related]
13. Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.
Lippa A; Czobor P; Stark J; Beer B; Kostakis E; Gravielle M; Bandyopadhyay S; Russek SJ; Gibbs TT; Farb DH; Skolnick P
Proc Natl Acad Sci U S A; 2005 May; 102(20):7380-5. PubMed ID: 15870187
[TBL] [Abstract][Full Text] [Related]
14. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
[TBL] [Abstract][Full Text] [Related]
15. Further investigation of the stimulus properties of chlordiazepoxide and zolpidem. Agonism and antagonism by two novel benzodiazepines.
Sanger DJ
Psychopharmacology (Berl); 1987; 93(3):365-8. PubMed ID: 2829266
[TBL] [Abstract][Full Text] [Related]
16. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.
Munro G; Lopez-Garcia JA; Rivera-Arconada I; Erichsen HK; Nielsen EØ; Larsen JS; Ahring PK; Mirza NR
J Pharmacol Exp Ther; 2008 Dec; 327(3):969-81. PubMed ID: 18791060
[TBL] [Abstract][Full Text] [Related]
18. Limited central side effects of a β-subunit subtype-selective GABAA receptor allosteric modulator.
Yoshimura RF; Tran MB; Hogenkamp DJ; Johnstone TB; Xie JY; Porreca F; Gee KW
J Psychopharmacol; 2014 May; 28(5):472-8. PubMed ID: 24108410
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats.
Rowlett JK; Woolverton WL
J Pharmacol Exp Ther; 1997 Jan; 280(1):162-73. PubMed ID: 8996194
[TBL] [Abstract][Full Text] [Related]
20. NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy.
Mirza NR; Larsen JS; Mathiasen C; Jacobsen TA; Munro G; Erichsen HK; Nielsen AN; Troelsen KB; Nielsen EØ; Ahring PK
J Pharmacol Exp Ther; 2008 Dec; 327(3):954-68. PubMed ID: 18791063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
